NCT01575483View on ClinicalTrials.gov

Korean Post-marketing Surveillance for Onglyza®

CompletedOBSERVATIONAL

Enrollment

3,433

Participants

Timeline

Start Date

March 1, 2012

Primary Completion Date

September 7, 2016

Study Completion Date

September 7, 2016

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG

No Intervention (subjects were previously treated with Onglyza®)

No Intervention

Trial Locations (1)

Unknown

Research Site, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY